CSF dopamine, serotonin, and biopterin metabolites in patients with restless legs syndrome.
about
Abnormally increased CSF 3-Ortho-methyldopa (3-OMD) in untreated restless legs syndrome (RLS) patients indicates more severe disease and possibly abnormally increased dopamine synthesisMotor restlessness, sleep disturbances, thermal sensory alterations and elevated serum iron levels in Btbd9 mutant mice.Update in restless legs syndromeTreating restless legs syndrome: current pathophysiological concepts and clinical trials.The dopamine transporter is decreased in the striatum of subjects with restless legs syndromeQuantitative trait loci mapping and gene network analysis implicate protocadherin-15 as a determinant of brain serotonin transporter expression.Periodic leg movements in sleep in elderly patients with Parkinsonism and Alzheimer's disease.Ropinirole in the treatment of restless legs syndrome.Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome.Sleep/wake problems in Parkinson's disease: pathophysiology and clinicopathologic correlations.Connectome and molecular pharmacological differences in the dopaminergic system in restless legs syndrome (RLS): plastic changes and neuroadaptations that may contribute to augmentation.Animal models of RLS phenotypes.Management of restless legs syndrome in chronic liver disease: A challenge for the correct diagnosis and therapy.
P2860
Q24657853-9471BBDA-84B1-43D0-BE28-6A5C3B1A3E07Q28585548-9C7537CB-221F-4D52-A8A6-F4F2A3E19277Q34022894-F860D315-C23A-400A-B9AF-AF6063624D49Q34581494-8BCFDDC6-D0F6-42DB-B9AB-8EB4FD8AE765Q34585898-6A7C2026-457B-4A3B-AADE-ABBE43B2D162Q35621202-359D64F1-6254-45E3-B95D-542A532A5C66Q35957378-7F13E47C-ACF9-4C75-AA87-3C741BE2A785Q36106752-093ED4CB-596D-46F5-8B96-65B8FB5A8C42Q37319535-899B3D67-3B69-4774-8E43-1DDE9B5B696CQ38214475-1AF9A14E-C67F-48E9-88F2-DCC741ADC114Q38931189-C92FA7B8-4553-47CD-A65C-BC5733719ADCQ39007031-AAD4954A-A29D-4962-AFA7-7AF44C730E14Q54245394-752E7D73-DD79-42D7-A62F-52929FBAD1A2
P2860
CSF dopamine, serotonin, and biopterin metabolites in patients with restless legs syndrome.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
CSF dopamine, serotonin, and b ...... s with restless legs syndrome.
@ast
CSF dopamine, serotonin, and b ...... s with restless legs syndrome.
@en
type
label
CSF dopamine, serotonin, and b ...... s with restless legs syndrome.
@ast
CSF dopamine, serotonin, and b ...... s with restless legs syndrome.
@en
prefLabel
CSF dopamine, serotonin, and b ...... s with restless legs syndrome.
@ast
CSF dopamine, serotonin, and b ...... s with restless legs syndrome.
@en
P2093
P2860
P1433
P1476
CSF dopamine, serotonin, and b ...... s with restless legs syndrome.
@en
P2093
P2860
P304
P356
10.1002/1531-8257(200101)16:1<144::AID-MDS1009>3.0.CO;2-F
P407
P577
2001-01-01T00:00:00Z